Published in

Taylor and Francis Group, Current Medical Research and Opinion, 6(31), p. 1129-1137, 2015

DOI: 10.1185/03007995.2015.1037730

Links

Tools

Export citation

Search in Google Scholar

Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer

Journal article published in 2015 by Miguel Martín, Milagros González-Rivera, Serafín Morales ORCID, Juan de la Haba-Rodriguez, Lucía González-Cortijo, Luis Manso, Joan Albanell, Antonio González-Martín, Sónia González, Angels Arcusa, Luis de la Cruz-Merino, Federico Rojo, María Vidal ORCID, Patricia Galván ORCID, Elena Aguirre and other authors.
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO